{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:59:01Z","timestamp":1788969541190,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.autrev.2023.103400","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:15:19Z","timestamp":1689995719000},"page":"103400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission"],"prefix":"10.1016","volume":"22","author":[{"given":"Roberto","family":"Giacomelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Colafrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Leccese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sfriso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gabini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tirri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Lo","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Quartuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Gattamelata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Paroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Picchianti-Diamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Domenico","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Favalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Frassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Faggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tomelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Marotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Colaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Padula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Sota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvise","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Grava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bindoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosetta","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103400_bb0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103400_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103400_bb0015","article-title":"Macrophage activation syndrome associated with adult-onset Still\u2019s disease successfully treated with Anakinra","volume":"2016","author":"Kumar","year":"2016","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0020","article-title":"Adult-onset Still\u2019s disease: not always so good","volume":"30","author":"Priori","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112810","article-title":"Adult-onset Still\u2019s disease-a complex disease, a challenging treatment","volume":"23","author":"Macovei","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103400_bb0030","series-title":"Still disease","author":"Bhargava","year":"2023"},{"key":"10.1016\/j.autrev.2023.103400_bb0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","article-title":"How I treat patients with adult onset Still's disease in clinical practice","volume":"16","author":"Govoni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103400_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-019-2021-9","article-title":"Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts","volume":"21","author":"Colafrancesco","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103400_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/14397595.2018.1465633","article-title":"Evidence-based clinical practice guideline for adult Still's disease","volume":"28","author":"Mimura","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0050","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still\u2019s disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/s10165-008-0126-0","article-title":"Cyclosporin a treatment for Japanese patients with severe adult-onset Still\u2019s disease","volume":"19","author":"Mitamura","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"Suppl. 127","key":"10.1016\/j.autrev.2023.103400_bb0060","first-page":"11","article-title":"Calcineurin inhibitors for adult-onset Still\u2019s disease: a multicentre retrospective cohort study","volume":"38","author":"Nakamura","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0065","article-title":"Adult-onset Still\u2019s disease: a disease at the crossroad of innate immunity and autoimmunity","volume":"9","author":"Rao","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103400_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","article-title":"Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still\u2019s disease: data from a large multicenter cohort","volume":"69","author":"Kalyoncu","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103400_bb0075","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/annrheumdis-2019-eular.4904","article-title":"Treatment review of adult-onset Still\u2019s disease in a tertiary hospital, meeting abstract","volume":"78","author":"Arcila Duran","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0080","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103400_bb0085","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","article-title":"Therapeutic responses and prognosis in adult-onset Still\u2019s disease","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103400_bb0090","first-page":"331","article-title":"Adult onset Still\u2019s disease: review of 41 cases","volume":"29","author":"Riera","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0095","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.080365","article-title":"Clinical features and prognosis of adult-onset still\u2019s disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0100","first-page":"1582","article-title":"Cyclosporin a in the treatment of adult onset Still\u2019s disease","volume":"24","author":"Marchesoni","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10067-007-0648-4","article-title":"Adult onset Still\u2019s disease: a study of 14 cases","volume":"27","author":"Singh","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0110","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13075-022-02780-3","article-title":"Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease","volume":"24","author":"Kondo","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103400_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2023.103400_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13075-020-02245-5","article-title":"Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients","volume":"22","author":"Ruscitti","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103400_bb0130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13075-021-02688-4","article-title":"Clinical phenotypes and prognostic factors of adult-onset Still's disease: data from a large inpatient cohort","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103400_bb0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"Lequerre","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0140","first-page":"13","article-title":"Meaningful effect of anakinra in adult onset Still\u2019s disease (AOSD)","volume":"124","author":"Nordstrom","year":"2010","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2023.103400_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.46497\/ArchRheumatol.2022.8669","article-title":"Biological treatment in resistant adult-onset Still\u2019s disease: a single-center, retrospective cohort study","volume":"37","author":"Colak","year":"2022","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/annrheumdis-2014-eular.5607","article-title":"Efficacy of Anakinra in refractory adult-onset Still\u2019s disease: multicenter open-label study of 34 patients, THU0390","volume":"73","author":"Ortiz Sanju\u00e1n","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2020.09.014","article-title":"Drug retention rates of biological agents in adult onset Still's disease","volume":"51","author":"Campochiaro","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103400_bb0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","article-title":"Macrophage activation syndrome complicating adult onset Still\u2019s disease: a single center case series and comparison with literature","volume":"45","author":"Lenert","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103400_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa109.017","article-title":"Use of anakinra for haemophagocytic lymphohistiocytosis in adults, EP18","volume":"59","author":"Sammut","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2023.103400_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006656","article-title":"Refractory adult-onset still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8 mg\/kg\/d) of anakinra","volume":"96","author":"Parisi","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103400_bb0175","article-title":"Successful use of canakinumab in adult-onset still\u2019s disease refractory to short acting IL-1 inhibitors, THU0401","volume":"71","author":"Efthimiou","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8054961","article-title":"Real-life data on the efficacy of Canakinumab in patients with adult-onset Still\u2019s disease","volume":"2020","author":"Vitale","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2023.103400_bb0185","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/annrheumdis-2020-eular.2352","article-title":"Efficacy and safety of canakinumab in adult-onset Still\u2019s disease: a single-cencer real-life experience, FRI0506","volume":"79","author":"Tomelleri","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2020.10.011","article-title":"Outcome of refractory to conventional and\/or biologic treatment adult Still\u2019s disease following canakinumab treatment: countrywide data in 50 patients","volume":"51","author":"Laskari","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103400_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fmed.2020.00042","article-title":"Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes","volume":"7","author":"Vitale","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103400_bb0200","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3899\/jrheum.130881","article-title":"Tocilizumab in adult-onset Still\u2019s disease: the Israeli experience","volume":"41","author":"Elkayam","year":"2014","journal-title":"J Rheumatol"},{"issue":"Suppl. 10","key":"10.1016\/j.autrev.2023.103400_bb0205","first-page":"S1","article-title":"Efficacy of tocilizumab therapy in Korean patients with adults onset still\u2019s disease: multicenter retrospective study of 20 cases arthritis","volume":"66","author":"Kim","year":"2014","journal-title":"Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/annrheumdis-2017-eular.4922","article-title":"Tocilizumab monotherapy for adult onset still\u2019s disease \u2013 results of 52-week treatment of a prospective, single-center, single-arm, open trial","volume":"76","author":"Kondo","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0215","first-page":"S1","article-title":"Efficacy of tocilizumab in refractory adult-onset Still\u2019s disease: multicenter study of 32 patients","volume":"65","author":"Ortiz Sanjuan","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103400_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.3299","article-title":"SAT0525\u00a0tocilizumab compared with anakinra in refractory adult-onset still\u2019s disease. Multicenter study of 75 patients","volume":"74","author":"Palmou","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-eular.4994","article-title":"Biologic agents in refractory adult Still\u2019s disease: better response rates and acceptable safety with Anakinra and tocilizumab, FRI0502","volume":"75","author":"Toz","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0230","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00296-020-04622-4","article-title":"Treatment of refractory adult onset Still\u2019s disease with tocilizumab-a single Centre experience and literature review","volume":"40","author":"Reihl Crnogaj","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103400_bb0235","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/annrheumdis-2020-eular.4120","article-title":"Biologics in adult-onset Still\u2019s disease: treatment strategies and safety in single center cohort with long-term follow-up, AB1041","volume":"79","author":"Kougkas","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","article-title":"Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy","volume":"21","author":"Vercruysse","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103400_bb0245","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","article-title":"Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies","volume":"13","author":"Ruscitti","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103400_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/TCRM.S155488","article-title":"Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review","volume":"14","author":"Zhou","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.autrev.2023.103400_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/03009742.2014.992949","article-title":"Efficacy and safety of biological agents in adult-onset Still\u2019s disease","volume":"44","author":"Cavalli","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0260","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients","volume":"35","author":"Sfriso","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fphar.2017.00369","article-title":"Response to Interleukin-1 inhibitors in 140 Italian patients with adult-onset Still\u2019s disease: a multicentre retrospective observational study","volume":"8","author":"Colafrancesco","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2023.103400_bb0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-019-04358-w","article-title":"Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre \"real-life\" cohort","volume":"40","author":"Ruscitti","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103400_bb0275","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.21901","article-title":"Fautrel and cri, Anakinra in adult-onset Still\u2019s disease: long-term treatment in patients resistant to conventional therapy","volume":"65","author":"Giampietro","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2023.103400_bb0280","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fphar.2019.00296","article-title":"Long-term retention rate of Anakinra in adult onset Still\u2019s disease and predictive factors for treatment response","volume":"10","author":"Vitale","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2023.103400_bb0285","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/art.41488","article-title":"Tapering canakinumab monotherapy in patients with systemic juvenile idiopathic arthritis in clinical remission: results from a phase IIIb\/IV open-label, randomized study","volume":"73","author":"Quartier","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0290","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/art.40865","article-title":"Treatment to target using recombinant Interleukin-1 receptor antagonist as first-line monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five-year follow-up study","volume":"71","author":"Ter Haar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0295","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/14740338.2020.1839411","article-title":"Current treatment options and safety considerations when treating adult-onset Still's disease","volume":"19","author":"Cavalli","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.autrev.2023.103400_bb0300","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0305","doi-asserted-by":"crossref","first-page":"1071732","DOI":"10.3389\/fmed.2022.1071732","article-title":"Canakinumab as first-line biological therapy in Still\u2019s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry","volume":"9","author":"Vitale","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103400_bb0310","article-title":"Anakinra treatment in refractory cases of adult-onset still disease: case series","volume":"77","author":"Ugurlu","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14712\/18059694.2016.51","article-title":"Efficacy of low-dose tocilizumab on relapsing adult-onset Still\u2019s disease","volume":"59","author":"Vandemergel","year":"2016","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.autrev.2023.103400_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152139","article-title":"Systematic review on the use of biologics in adult-onset still's disease","volume":"58","author":"Fautrel","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103400_bb0325","article-title":"Canakinumab treatment in adult-onset still\u2019s disease: case series","volume":"77","author":"Ugurlu","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103400_bb0330","first-page":"1598","article-title":"Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease","volume":"40","author":"Campochiaro","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103400_bb0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13075-021-02507-w","article-title":"Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease","volume":"23","author":"Segu-Verges","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103400_bb0340","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015123","article-title":"Managing adult-onset Still\u2019s disease: the effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study","volume":"98","author":"Ruscitti","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:31:03Z","timestamp":1761600663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1568997223001349"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103400","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103400"}}